BioCentury | Dec 15, 2020
Finance

Dec. 14 Quick Takes: Locanabio raises $100M series B; plus rare bleeding disorder newco Hemab, raises for Rani, CG, InnoSkel, Denovo, Biosion and more

...immunology and oncology, including anti-TSLP and anti-CD40 mAbs, via in-house discovery and in-licensing.HighTide completes series B+Shenzhen HighTide Biopharmaceutical Ltd....
...LLC CICC Qide Yingke PE China Resources Pharmaceutical Sangel Capital Zheshang Industrial Integration Asset Management Biosion Inc. Lapam Capital Kaiyuan Capital Oceanpine Healthcare Fund Zheshang Innovest Shenzhen HighTide Biopharmaceutical Ltd. Greater...
Items per page:
1 - 1 of 1
BioCentury | Dec 15, 2020
Finance

Dec. 14 Quick Takes: Locanabio raises $100M series B; plus rare bleeding disorder newco Hemab, raises for Rani, CG, InnoSkel, Denovo, Biosion and more

...immunology and oncology, including anti-TSLP and anti-CD40 mAbs, via in-house discovery and in-licensing.HighTide completes series B+Shenzhen HighTide Biopharmaceutical Ltd....
...LLC CICC Qide Yingke PE China Resources Pharmaceutical Sangel Capital Zheshang Industrial Integration Asset Management Biosion Inc. Lapam Capital Kaiyuan Capital Oceanpine Healthcare Fund Zheshang Innovest Shenzhen HighTide Biopharmaceutical Ltd. Greater...
Items per page:
1 - 1 of 1